Published in Am J Psychiatry on July 01, 1991
Ect and t(2) relaxometry: a static walter proton magnetic resonance imaging study. Indian J Psychiatry (2001) 0.84
Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London) (2014) 0.78
Delayed amnesia and disorientation after electroconvulsive treatment. J Psychiatry Neurosci (1992) 0.75
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) 5.86
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Psychomotor symptoms of depression. Am J Psychiatry (1997) 2.45
Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry (1996) 2.32
Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry (2000) 2.30
Memory and ECT: from polarization to reconciliation. J ECT (2000) 2.18
Electro-convulsive therapy practices in the community. Psychol Med (2001) 2.15
Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry (1994) 2.12
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene (2001) 2.08
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. J ECT (2000) 1.89
Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry (2001) 1.88
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84
Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry (2001) 1.80
Does ECT alter brain structure? Am J Psychiatry (1994) 1.78
Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry (2001) 1.74
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry (2000) 1.61
Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61
Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry (1996) 1.56
Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT (2000) 1.56
Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res (1979) 1.52
Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J Biol Chem (1988) 1.50
Pulmonary function profile in patients with benign goiters without symptoms of respiratory compromise and the early effect of thyroidectomy. J Postgrad Med (2008) 1.48
Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry (1997) 1.44
Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression. Am J Geriatr Psychiatry (2000) 1.44
Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. J ECT (2000) 1.44
Hemispheric asymmetry in the expression of positive and negative emotions. Neurologic evidence. Arch Neurol (1982) 1.43
Does ECT permanently alter seizure threshold? Biol Psychiatry (1993) 1.41
Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry (1999) 1.38
Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry (1998) 1.38
A unilateral, prolonged, nonconvulsive seizure in a patient treated with bilateral ECT. J ECT (2001) 1.38
Predictors of retrograde amnesia following ECT. Am J Psychiatry (1995) 1.35
Decreased regional brain metabolism after ect. Am J Psychiatry (2001) 1.33
Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res (1990) 1.32
Emotions are expressed more intensely on the left side of the face. Science (1978) 1.31
Different brain networks mediate task performance in normal aging and AD: defining compensation. Neurology (2000) 1.28
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Res (1978) 1.27
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res (2001) 1.26
Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res (1977) 1.22
Magnetic seizure therapy of major depression. Arch Gen Psychiatry (2001) 1.22
The rate of activation by calmodulin of isoform 4 of the plasma membrane Ca(2+) pump is slow and is changed by alternative splicing. J Biol Chem (1999) 1.21
The Ca2+ affinity of the plasma membrane Ca2+ pump is controlled by alternative splicing. J Biol Chem (1994) 1.20
Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry (1987) 1.20
A highly active 120-kDa truncated mutant of the plasma membrane Ca2+ pump. J Biol Chem (1993) 1.18
Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem J (1996) 1.17
Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India (2003) 1.15
Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.15
Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry (1999) 1.14
Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res (2000) 1.13
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia (2010) 1.13
A pilot study of same day sputum smear examination, its feasibility and usefulness in diagnosis of pulmonary TB. Indian J Tuberc (2011) 1.12
Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1999) 1.11
Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology (1988) 1.10
Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res (1982) 1.08
Protein kinase C activates the plasma membrane Ca2+ pump isoform 4b by phosphorylation of an inhibitory region downstream of the calmodulin-binding domain. J Biol Chem (1996) 1.07
Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer (2001) 1.07
Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol (1989) 1.06
Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer. World J Surg (2015) 1.05
Uptake of insulin by plasmalemma and Golgi subcellular fractions of rat liver. J Biol Chem (1980) 1.05
ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord (2001) 1.03
Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry (1998) 1.03
Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry (1999) 1.03
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect (2004) 1.02
Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency. World J Surg (2008) 1.02
Protein kinase C phosphorylates the "a" forms of plasma membrane Ca2+ pump isoforms 2 and 3 and prevents binding of calmodulin. J Biol Chem (1997) 1.02
Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry (2001) 1.02
Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol Pharmacol (1999) 1.00
Intracellular hormone receptors: evidence for insulin and lactogen receptors in a unique vesicle sedimenting in lysosome fractions of rat liver. Proc Natl Acad Sci U S A (1981) 1.00
Overexpression of the erythrocyte plasma membrane Ca2+ pump in COS-1 cells. Biochem J (1992) 1.00
Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg (2010) 1.00
Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry (1983) 0.99
Antibodies directed toward human erythrocyte Ca2+-ATPase: effect on enzyme function and immunoreactivity of Ca2+-ATPases from other sources. Arch Biochem Biophys (1982) 0.98
Functional impression technique for an ocular prosthesis. J Indian Prosthodont Soc (2011) 0.98
Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT (1999) 0.98
Cervical lymphadenopathy: scrofula revisited. J Laryngol Otol (2008) 0.98
Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr (1992) 0.97
Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci (1986) 0.97
The effects of pain and depression on physical functioning in elderly residents of a continuing care retirement community. Pain Med (2000) 0.97
Molecular properties of calcium-pumping ATPase from human erythrocytes. Biochemistry (1982) 0.97
Differences in the distribution of gray and white matter in human cerebral hemispheres. Science (1980) 0.97
Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J Surg (2007) 0.97
A paradox in depression: uncontrollability and self-blame. Psychol Bull (1977) 0.96
Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Res (1987) 0.96
Fine needle aspiration cytology of salivary gland lesions. J Oral Pathol Med (1994) 0.96
Psychosis, behavioral disturbance, and the use of neuroleptics in dementia. Compr Psychiatry (1988) 0.96
Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res (1987) 0.95
The housefly (Musca domestica) as a carrier of pathogenic microorganisms in a hospital environment. J Hosp Infect (1992) 0.95
Cardiac arrest during ECT modified by beta-adrenergic blockade. Am J Psychiatry (1984) 0.94
Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. Biochem Biophys Res Commun (1982) 0.94
Isolation of phytase-producing bacteria from Himalayan soils and their effect on growth and phosphorus uptake of Indian mustard (Brassica juncea). World J Microbiol Biotechnol (2013) 0.94
Calcium pump epitopes in placental trophoblast basal plasma membranes. Am J Physiol (1989) 0.93
Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. Cancer Res (1979) 0.93
Convulsive therapy in schizophrenia? Schizophr Bull (1996) 0.93
The development of mania and organic euphoria during ECT. J Clin Psychiatry (1988) 0.92
Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsychopharmacology (1999) 0.92